{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T17:30:27Z","timestamp":1771522227140,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 DA 15999-01"],"award-info":[{"award-number":["RO1 DA 15999-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001027","name":"Department of Health and Ageing, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007220","name":"VicHealth","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007220","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1053\/j.gastro.2009.09.019","type":"journal-article","created":{"date-parts":[[2009,9,25]],"date-time":"2009-09-25T12:47:48Z","timestamp":1253882868000},"page":"123-135.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection"],"prefix":"10.1053","volume":"138","author":[{"given":"Gregory J.","family":"Dore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Hellard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail V.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Grebely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul S.","family":"Haber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Petoumenos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippa","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"van Beek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"McCaughan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Rawlinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Kaldor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2009.09.019_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1053\/j.gastro.2009.09.019_bib2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1572-0241.2005.40976.x","article-title":"Estimation of utilities for chronic hepatitis C from SF-36 scores","volume":"100","author":"Thein","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2009.09.019_bib3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/jhep.2001.27831","article-title":"Estimating progression to cirrhosis in chronic hepatitis C virus infection","volume":"34","author":"Freeman","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2009.09.019_bib4","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1053\/j.gastro.2006.01.034","article-title":"Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response","volume":"130","author":"Kamal","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2009.09.019_bib5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/jac\/dki458","article-title":"Dose-dependent and genotype-independent sustained virological response of a 12 week pegylated interferon alpha-2b treatment for acute hepatitis C","volume":"57","author":"De Rosa","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1053\/j.gastro.2009.09.019_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2004.11.021","article-title":"Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance","volume":"42","author":"Santantonio","year":"2005","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2009.09.019_bib7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.21043","article-title":"Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study","volume":"43","author":"Wiegand","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2009.09.019_bib8","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hep.21197","article-title":"Duration of peginterferon therapy in acute hepatitis C: a randomized trial","volume":"43","author":"Kamal","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2009.09.019_bib9","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1056\/NEJMoa011232","article-title":"Treatment of acute hepatitis C with interferon alfa-2b","volume":"345","author":"Jaeckel","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2009.09.019_bib10","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/hep.20266","article-title":"Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics","volume":"39","author":"Kamal","year":"2004","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2009.09.019_bib11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0016-5085(03)00668-1","article-title":"Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance","volume":"125","author":"Gerlach","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2009.09.019_bib12","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0168-8278(03)00461-6","article-title":"When and how to treat acute hepatitis C?","volume":"39","author":"Licata","year":"2003","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2009.09.019_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jhep.2008.07.005","article-title":"Acute hepatitis C: current status and remaining challenges","volume":"49","author":"Santantonio","year":"2008","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2009.09.019_bib14","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1360-0443.1992.tb02719.x","article-title":"Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index","volume":"87","author":"Darke","year":"1992","journal-title":"Br J Addict"},{"issue":"Suppl 20","key":"10.1053\/j.gastro.2009.09.019_bib15","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1053\/j.gastro.2009.09.019_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1348\/014466505X29657","article-title":"The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample","volume":"44","author":"Henry","year":"2005","journal-title":"Br J Clin Psychol"},{"issue":"Suppl 4","key":"10.1053\/j.gastro.2009.09.019_bib17","first-page":"779A","article-title":"Natural history of HCV superinfection and reinfection","volume":"48","author":"White","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2009.09.019_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2893.2006.00802.x","article-title":"A short course of pegylated interferon-alpha in acute HCV hepatitis","volume":"14","author":"Calleri","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1053\/j.gastro.2009.09.019_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jhep.2004.11.018","article-title":"Barriers to interferon-alpha therapy are higher in intravenous drug users than in other patients with acute hepatitis C","volume":"42","author":"Broers","year":"2005","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2009.09.019_bib20","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/hep.1840360706","article-title":"Natural history of chronic hepatitis C","volume":"36","author":"Seeff","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2009.09.019_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1089-3261(02)00077-6","article-title":"Current therapy for hepatitis C: pegylated interferon and ribavirin","volume":"7","author":"McHutchison","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1053\/j.gastro.2009.09.019_bib22","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/MEG.0b013e3281bcb8d8","article-title":"Adherence to hepatitis C treatment in recovering heroin users maintained on methadone","volume":"19","author":"Sylvestre","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2009.09.019_bib23","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/596770","article-title":"Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C","volume":"48","author":"Matthews","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.gastro.2009.09.019_bib24","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/135965350601100817","article-title":"Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals","volume":"11","author":"Vogel","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1053\/j.gastro.2009.09.019_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.qai.0000174930.64145.a9","article-title":"Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin","volume":"40","author":"Gilleece","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/j.gastro.2009.09.019_bib26","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa040842","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients","volume":"351","author":"Torriani","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2009.09.019_bib27","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1001\/jama.292.23.2839","article-title":"Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial","volume":"292","author":"Carrat","year":"2004","journal-title":"JAMA"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508509016606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508509016606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:38:11Z","timestamp":1762162691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508509016606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0016508509016606"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2009.09.019","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2009.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}